NCT00276302 2011-01-06Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)Infinity Pharmaceuticals, Inc.Phase 1 Completed63 enrolled